Stay updated on Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial
Sign up to get notified when there's something new on the Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial page.

Latest updates to the Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new page revision entry 'Revision: v3.4.2' was added to the history, and the previous funding-lapse notice and 'Revision: v3.4.1' were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about government funding and a version update to v3.4.1 (replacing v3.4.0) were added. These changes do not affect trial data or navigation on the record page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedThe study history page adds a glossary toggle, color-coded additions and deletions, and a new revision label, representing UI and formatting updates rather than changes to the underlying study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check35 days agoChange DetectedA new revision entry (v3.3.4) was added and the previous revision (v3.3.3) was removed from the history.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry, Revision: v3.3.3, has been added to the history, and the HHS Vulnerability Disclosure item and the Revision: v3.3.2 entry were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check86 days agoChange DetectedA new revision entry v3.3.2 was added to the history, and the previous v3.3.1 entry was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial page.